PLACEBO, ISMIGEN tabletki podjezykowe clinical trials

A randomized double-blind placebo-controlled study to demonstrate the efficacy of PMBL® sublingual tablets in reducing the incidence of respiratory tract infections in children aged 3-12 years (PIRTIK).

This study looks at whether a sublingual (under-the-tongue) tablet, called PMBL®, can help reduce the number of breathing infections in children aged 3 to 12. We want to see if it makes children sick less often and for shorter periods.